Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human Utrophin ELISA Kit (AC3822)
Cat.#: ASET-2411
Specifications
Description Human Utrophin ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Utrophin concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.108 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 2.5-40 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1398 Human nNOS (neuronal) ELISA Kit (AC2809) Quantitative inquiry ASET-1912 Rat NMDAR1 ELISA Kit (AC3323) Quantitative inquiry ASET-2322 Bovine Luteinizing Hormone ELISA Kit (AC3733) Quantitative inquiry ASET-1193 Human SPON2 ELISA Kit (AC2604) Quantitative inquiry ASET-1146 Human Urocortin ELISA Kit (AC2557) Quantitative inquiry ASET-1216 Mouse VEGFC ELISA Kit (AC2627) Quantitative inquiry ASET-1682 Human Somatostatin ELISA Kit (AC3093) Quantitative inquiry ASET-1640 Dopamine ELISA Kit (AC3051) Quantitative inquiry ASET-2093 Human HEXA ELISA Kit (AC3504) Quantitative inquiry ASET-1353 Human Eph Receptor A3 ELISA Kit (AC2764) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket